Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Behjatolah Karbassi

Concepts (272)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antigens, Tumor-Associated, Carbohydrate
15
2023
24
3.880
Why?
Cancer Vaccines
13
2022
78
2.650
Why?
Peptides
17
2022
223
2.590
Why?
Carbohydrates
14
2009
40
2.400
Why?
Molecular Mimicry
13
2007
38
2.030
Why?
Breast Neoplasms
12
2024
1184
1.730
Why?
Neoplasms
9
2022
1250
1.500
Why?
Immunotherapy
6
2022
240
1.110
Why?
Epitopes, T-Lymphocyte
6
2009
24
0.910
Why?
HIV Envelope Protein gp120
4
2009
9
0.850
Why?
Lung Neoplasms
4
2014
609
0.840
Why?
HIV-1
4
2009
54
0.820
Why?
Antibodies, Neoplasm
2
2017
28
0.820
Why?
Mice, Inbred BALB C
16
2011
306
0.800
Why?
Antigens
4
2003
41
0.780
Why?
Animals
31
2023
13285
0.670
Why?
Epithelial-Mesenchymal Transition
2
2020
48
0.660
Why?
Clinical Trials, Phase I as Topic
2
2017
25
0.630
Why?
Gene Expression Regulation, Neoplastic
5
2020
828
0.630
Why?
Vaccines, DNA
6
2006
11
0.620
Why?
Immunologic Surveillance
2
2009
10
0.620
Why?
HIV Antigens
3
2006
9
0.590
Why?
Epitopes
3
2009
61
0.580
Why?
Cell Transformation, Neoplastic
1
2018
179
0.570
Why?
Immunity, Innate
3
2018
105
0.540
Why?
Antineoplastic Agents
3
2017
1186
0.540
Why?
Molecular Targeted Therapy
1
2017
121
0.530
Why?
Neoplasm Proteins
1
2018
324
0.520
Why?
Mice
20
2011
5770
0.510
Why?
Cell Hypoxia
1
2015
82
0.490
Why?
Biomimetic Materials
1
2014
10
0.490
Why?
Epigenesis, Genetic
1
2018
378
0.480
Why?
Estrogen Receptor alpha
1
2015
88
0.480
Why?
Vaccines
4
2002
49
0.460
Why?
T-Lymphocytes
7
2010
339
0.450
Why?
Cross Reactions
8
2006
42
0.440
Why?
Oligosaccharides
4
2007
35
0.440
Why?
Amino Acid Sequence
9
2006
587
0.440
Why?
Sarcoma, Experimental
2
2004
13
0.430
Why?
Molecular Sequence Data
9
2006
793
0.430
Why?
Humans
35
2024
50251
0.430
Why?
Polysaccharides
2
2011
51
0.430
Why?
Antigens, Neoplasm
5
2007
152
0.420
Why?
AIDS Vaccines
3
2009
8
0.410
Why?
Isoflavones
1
2023
87
0.410
Why?
Plant Lectins
2
2010
8
0.400
Why?
Sulfotransferases
3
2020
40
0.390
Why?
Chondroitin Sulfates
2
2011
13
0.380
Why?
P-Selectin
2
2011
32
0.380
Why?
Soybean Proteins
1
2023
160
0.380
Why?
CD8-Positive T-Lymphocytes
3
2007
127
0.370
Why?
Fructose
1
2010
22
0.360
Why?
Autoantigens
1
2011
60
0.360
Why?
Adaptive Immunity
1
2010
31
0.360
Why?
Carbon
1
2010
54
0.350
Why?
Vaccines, Subunit
3
2006
15
0.340
Why?
CD4-Positive T-Lymphocytes
3
2006
163
0.340
Why?
Obesity
2
2023
1106
0.330
Why?
Drug Delivery Systems
1
2010
146
0.310
Why?
Carcinoma, Ductal
1
2008
9
0.310
Why?
Proteoglycans
3
2023
81
0.300
Why?
Mammary Neoplasms, Experimental
2
2005
121
0.300
Why?
Interferon-gamma
4
2018
176
0.300
Why?
Carcinoma in Situ
1
2008
72
0.290
Why?
Cell Line, Tumor
6
2011
1418
0.290
Why?
Dendritic Cells
3
2005
133
0.280
Why?
T-Lymphocytes, Cytotoxic
5
2009
65
0.280
Why?
Female
18
2024
26668
0.280
Why?
Concanavalin A
2
2005
15
0.260
Why?
HIV Infections
1
2009
357
0.250
Why?
Sarcoma
1
2006
67
0.250
Why?
Mammary Neoplasms, Animal
1
2005
35
0.250
Why?
Ligands
5
2011
204
0.240
Why?
MCF-7 Cells
4
2020
69
0.240
Why?
Neoplasm Metastasis
5
2015
236
0.240
Why?
Magnetic Resonance Spectroscopy
1
2005
245
0.240
Why?
Acetylglucosamine
1
2004
6
0.240
Why?
Histocompatibility Antigens Class I
1
2004
44
0.230
Why?
Combined Modality Therapy
2
2017
641
0.230
Why?
Immunoglobulin G
2
2003
186
0.220
Why?
Immunotherapy, Active
1
2003
4
0.220
Why?
Melanoma
1
2007
290
0.220
Why?
Peptide Fragments
1
2004
211
0.210
Why?
Peptide Library
4
2005
16
0.210
Why?
Autoantibodies
2
2018
116
0.210
Why?
Glycosylation
3
2010
102
0.210
Why?
Cell Proliferation
4
2020
1015
0.200
Why?
Antigens, Viral
1
2002
44
0.200
Why?
Antibodies, Monoclonal
5
2023
461
0.200
Why?
Apoptosis
2
2020
1115
0.200
Why?
Biochemistry
1
2001
5
0.190
Why?
Liver Neoplasms
1
2005
328
0.190
Why?
Enzyme-Linked Immunosorbent Assay
3
2010
244
0.190
Why?
Cell Adhesion
3
2006
158
0.180
Why?
CHO Cells
3
2006
121
0.180
Why?
Carbamates
1
2020
17
0.180
Why?
Cricetinae
3
2006
212
0.170
Why?
Adjuvants, Immunologic
2
2014
51
0.170
Why?
Colchicine
1
2020
29
0.170
Why?
Antineoplastic Agents, Phytogenic
1
2020
71
0.170
Why?
Carcinoma, Ductal, Breast
1
2020
90
0.160
Why?
Neoplastic Stem Cells
1
2020
103
0.160
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2020
92
0.160
Why?
Tumor Microenvironment
2
2024
233
0.160
Why?
Anthroposophy
1
2018
1
0.160
Why?
Tumor Cells, Cultured
3
2015
468
0.160
Why?
Antibody Formation
3
2003
51
0.150
Why?
Gene-Environment Interaction
1
2018
36
0.150
Why?
Cell Division
3
2006
295
0.150
Why?
Immunization
3
2004
66
0.150
Why?
Plant Extracts
1
2020
172
0.150
Why?
Chondroitin Sulfate Proteoglycans
2
2023
18
0.150
Why?
Immune Tolerance
2
2009
95
0.150
Why?
Cell Movement
4
2020
249
0.150
Why?
Flow Cytometry
3
2006
478
0.150
Why?
Spleen
3
2004
172
0.140
Why?
Homeostasis
1
2018
201
0.140
Why?
Clinical Trials, Phase II as Topic
1
2017
44
0.140
Why?
Forecasting
1
2017
149
0.130
Why?
HIV Antibodies
2
2006
10
0.130
Why?
Models, Immunological
2
2007
8
0.130
Why?
Membrane Proteins
2
2023
353
0.130
Why?
Phenotype
2
2010
732
0.120
Why?
Lectins
2
2006
14
0.120
Why?
Interleukin-12
2
2006
31
0.120
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2015
56
0.120
Why?
Coculture Techniques
1
2015
146
0.120
Why?
Drug Therapy
1
2014
46
0.120
Why?
Transforming Growth Factor beta
1
2015
144
0.120
Why?
Antibodies
1
2014
155
0.120
Why?
Adipocytes
1
2015
121
0.120
Why?
Vaccines, Conjugate
2
2005
7
0.110
Why?
Nuclear Proteins
1
2015
243
0.110
Why?
Cell Separation
2
2005
90
0.110
Why?
Rats, Zucker
1
2023
68
0.110
Why?
Scavenger Receptors, Class E
1
2015
204
0.110
Why?
Positron-Emission Tomography
1
2014
293
0.110
Why?
Cytotoxicity, Immunologic
2
2005
56
0.100
Why?
Mutation
1
2018
1296
0.100
Why?
Protein Binding
2
2005
668
0.100
Why?
Immunity, Cellular
2
2003
70
0.100
Why?
Mice, Nude
2
2004
254
0.100
Why?
C-Reactive Protein
1
2023
143
0.100
Why?
Lymphocyte Activation
3
2001
171
0.100
Why?
Kinetics
2
2005
632
0.100
Why?
Injections, Intramuscular
2
2003
54
0.100
Why?
Interleukin-6
1
2023
267
0.100
Why?
Binding Sites
2
2003
375
0.100
Why?
Prognosis
3
2020
1959
0.100
Why?
Tumor Necrosis Factor-alpha
1
2023
391
0.090
Why?
Microscopy, Phase-Contrast
1
2010
12
0.090
Why?
Lung
1
2014
504
0.090
Why?
Body Weight
1
2023
514
0.090
Why?
B-Lymphocytes
2
2002
170
0.090
Why?
DNA Methylation
1
2015
550
0.090
Why?
Transfection
3
2007
355
0.090
Why?
Substrate Specificity
1
2010
193
0.090
Why?
Antigens, CD
2
2003
221
0.090
Why?
Membrane Glycoproteins
2
2003
247
0.090
Why?
Actins
1
2010
119
0.090
Why?
Antibodies, Catalytic
1
2009
1
0.090
Why?
Receptors, CCR5
1
2009
6
0.090
Why?
Dose-Response Relationship, Drug
2
2005
1377
0.090
Why?
Neoplasm Invasiveness
1
2010
268
0.080
Why?
Cells, Cultured
2
2003
1583
0.080
Why?
Time Factors
2
2005
2911
0.080
Why?
Killer Cells, Natural
1
2009
108
0.080
Why?
Male
3
2023
25483
0.070
Why?
Fucosyltransferases
1
2007
5
0.070
Why?
Glycosaminoglycans
1
2007
19
0.070
Why?
Molecular Biology
1
2007
25
0.070
Why?
Binding Sites, Antibody
1
2006
16
0.070
Why?
Amino Acid Motifs
1
2006
58
0.070
Why?
Cricetulus
1
2006
108
0.070
Why?
Rats
1
2023
3312
0.070
Why?
Heparin
1
2007
91
0.070
Why?
Antineoplastic Agents, Alkylating
1
2006
74
0.070
Why?
E-Selectin
1
2005
14
0.070
Why?
Cell Membrane
1
2007
253
0.070
Why?
Xenograft Model Antitumor Assays
1
2006
213
0.060
Why?
Hydrocarbons
1
2005
5
0.060
Why?
Phosphorylcholine
1
2005
14
0.060
Why?
Cyclophosphamide
1
2006
166
0.060
Why?
Densitometry
1
2005
11
0.060
Why?
Mannose
1
2005
16
0.060
Why?
Wheat Germ Agglutinins
1
2005
3
0.060
Why?
Methane
1
2005
8
0.060
Why?
Surface Plasmon Resonance
1
2005
22
0.060
Why?
Bone Marrow Cells
1
2006
190
0.060
Why?
Growth Inhibitors
1
2005
27
0.060
Why?
Biosensing Techniques
1
2005
26
0.060
Why?
Glycolysis
1
2005
70
0.060
Why?
Genetic Variation
1
2006
215
0.060
Why?
Calcium
1
2007
400
0.060
Why?
Immunoglobulins
1
2005
80
0.060
Why?
Oligonucleotide Array Sequence Analysis
1
2006
412
0.060
Why?
Antigen Presentation
1
2004
25
0.060
Why?
Endothelial Cells
1
2006
270
0.060
Why?
Treatment Outcome
1
2014
5186
0.060
Why?
Bone Neoplasms
1
2006
183
0.060
Why?
Cytosol
1
2004
82
0.060
Why?
Immunoglobulin Constant Regions
1
2003
3
0.060
Why?
Middle Aged
2
2020
12234
0.060
Why?
Plasmids
2
2003
163
0.060
Why?
Recombinant Proteins
1
2005
489
0.060
Why?
Antibodies, Viral
1
2003
88
0.050
Why?
Histocompatibility Antigens Class II
1
2003
36
0.050
Why?
Immunoglobulin M
1
2003
52
0.050
Why?
Bacterial Capsules
1
2003
18
0.050
Why?
Th1 Cells
1
2003
52
0.050
Why?
DNA, Neoplasm
1
2003
147
0.050
Why?
Carbohydrate Metabolism
1
2002
26
0.050
Why?
Antibodies, Anti-Idiotypic
1
2002
19
0.050
Why?
Models, Chemical
1
2002
64
0.050
Why?
L-Selectin
1
2001
7
0.050
Why?
Calorimetry
1
2001
6
0.050
Why?
Carbohydrate Sequence
1
2001
11
0.050
Why?
Epitope Mapping
1
2001
6
0.050
Why?
Thermodynamics
1
2001
33
0.050
Why?
Binding, Competitive
1
2001
94
0.050
Why?
Mice, Inbred CBA
1
2001
35
0.050
Why?
Protein Structure, Secondary
1
2001
72
0.050
Why?
Gene Expression Profiling
1
2006
1041
0.050
Why?
Sequence Homology, Amino Acid
1
2001
144
0.050
Why?
Protein Conformation
1
2001
168
0.050
Why?
Antibody-Dependent Cell Cytotoxicity
1
2000
12
0.050
Why?
Injections, Intraperitoneal
1
2000
55
0.050
Why?
Colchicum
1
2020
4
0.040
Why?
Inhibitory Concentration 50
1
2020
75
0.040
Why?
Models, Molecular
1
2001
342
0.040
Why?
Drug Screening Assays, Antitumor
1
2020
140
0.040
Why?
Child, Preschool
1
2008
3877
0.040
Why?
Wnt Signaling Pathway
1
2020
92
0.040
Why?
H-2 Antigens
1
1999
3
0.040
Why?
Receptors, Estrogen
1
2020
131
0.040
Why?
Transformation, Genetic
1
1998
16
0.040
Why?
Clostridium
1
1998
15
0.040
Why?
Glycoside Hydrolases
1
1998
21
0.040
Why?
Cell Survival
1
2020
602
0.040
Why?
Plants
1
1998
28
0.040
Why?
Genes, Reporter
1
1998
88
0.040
Why?
Models, Biological
1
2001
726
0.040
Why?
Survival Rate
1
2020
902
0.040
Why?
Adolescent
1
2008
6402
0.030
Why?
Retrospective Studies
1
2008
6172
0.030
Why?
Child
1
2008
6854
0.030
Why?
CpG Islands
1
2015
107
0.030
Why?
Disease Progression
1
2015
827
0.020
Why?
RNA Interference
1
2011
179
0.020
Why?
RNA, Small Interfering
1
2011
215
0.020
Why?
Simian virus 40
1
2003
12
0.010
Why?
Lymphocyte Subsets
1
2003
13
0.010
Why?
Immunoglobulin Variable Region
1
2003
13
0.010
Why?
Mutagenesis, Site-Directed
1
2003
99
0.010
Why?
Sequence Deletion
1
2003
68
0.010
Why?
Protein Structure, Tertiary
1
2003
253
0.010
Why?
Recombinant Fusion Proteins
1
2003
187
0.010
Why?
Down-Regulation
1
2003
349
0.010
Why?
Up-Regulation
1
2003
452
0.010
Why?
Radiation Chimera
1
1999
3
0.010
Why?
HIV Envelope Protein gp160
1
1999
2
0.010
Why?
beta 2-Microglobulin
1
1999
38
0.010
Why?
Protein Engineering
1
1999
18
0.010
Why?
Plants, Toxic
1
1998
10
0.010
Why?
Enzyme Stability
1
1998
20
0.010
Why?
Plants, Genetically Modified
1
1998
18
0.010
Why?
Stem Cells
1
1999
171
0.010
Why?
Hot Temperature
1
1998
204
0.010
Why?
Signal Transduction
1
2003
1624
0.010
Why?
Mice, Knockout
1
1999
847
0.010
Why?
Mice, Inbred C57BL
1
1999
1823
0.010
Why?
Muscle, Skeletal
1
1999
765
0.010
Why?
Karbassi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description